Login to Your Account



Gel for Wound Healing

Firststring Off the (Lab) Bench: Granexin's Phase II Bids Strong

By Randy Osborne
Staff Writer

Tuesday, July 16, 2013
Firststring Research Inc.'s roll-out of positive, top-line Phase II news in three studies at the International Gap Junction Conference in Charleston, S.C., this week marks the emergence of the company from a low-profile mode.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription